CLEAN : Liberia: Trial for Potential Ebola Treatment Underway

The video discusses a treatment trial for Ebola in Liberia, focusing on the potential treatment brincidofovir (BCV). Patients with confirmed Ebola are screened and can voluntarily participate in the trial. Those who opt out receive standard care, while participants receive the trial medicine in addition to standard care. The trial aims to evaluate whether survival rates improve with the treatment compared to standard care alone.

What is the name of the drug being tested in the Ebola treatment trial?

• Favipiravir

• Brincidofovir

• Zidovudine

• Remdesivir

What happens to patients who choose not to participate in the trial?

• They are transferred to another facility.

• They receive no treatment.

• They are given a placebo.

• They receive standard care.

Which of the following is NOT part of the standard care for non-participating patients?

• Fluids

• Pain relief

• Trial medicine

• Food

What is the primary focus when evaluating the trial's success?

• Side effects

• Ease of administration

• Survival rates

• Cost of treatment

How is the trial medicine administered to participating patients?

• As a last resort

• In place of standard care

• In addition to standard care

• Only if standard care fails